Project Optimus (Ep. 21)
From Clinical Pharmacology Podcast with Nathan Teuscher · · 39 min
This plays from the publisher's own server. We do not host a copy.
Description
Today’s episode was about Project Optimus, the FDA initiative to improve dose selection and optimization for oncology products. Julie Bullock was a guest on this episode and shared her expertise as a former oncology clinical pharmacology reviewer at the FDA and as a current consultant in the pharmaceutical industry.
Links discussed in the show:
- Project Optimus FDA (https://go.teuschersolutions.com/projectoptimus)
- List of FDA (https://www.fda.gov/about-fda/oncology-center-excellence/project-optimus) guidances and publications for Project Optimus
- May 2022 FDA-ASCO workshop: Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology (https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/getting-dose-right-optimizing-dose-selection-strategies-oncology-fda-asco-virtual-workshop-05032022)
- Sept 2023 Second Annual FDA ASCO WORKSHOP on Getting the Dosage Right (https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/second-annual-fda-asco-workshop-getting-dosage-right-september-6-7-2023-09062023) (this one focused on combinations)
- Feb 2024 FDA/AACR Public Workshop: Optimizing Dosages for Oncology Drugs (https://www.aacr.org/professionals/policy-and-advocacy/regulatory-science-and-policy/events/fda-aacr-workshop-optimizing-dosages-for-oncology-drug-products/)
- You can connect with Julie on LinkedIn (https://www.linkedin.com/in/julie-bullock-ba6826/)
- You can connect with me on LinkedIn (https://go.teuschersolutions.com/linkedin) and send me a message
- Send me a message (https://go.teuschersolutions.com/contact)
- Sign up for my newsletter (https://go.teuschersolutions.com/newsletter)
Copyright Teuscher Solutions LLC
All Rights Reserved
Back to Clinical Pharmacology Podcast with Nathan Teuscher · Report a problem